Dataset Viewer
Vaccine
stringclasses 11
values | Dose
stringclasses 9
values | Geography Type
stringclasses 2
values | Geography
stringclasses 79
values | Birth Year/Birth Cohort
stringclasses 21
values | Dimension Type
stringclasses 6
values | Dimension
stringclasses 26
values | Estimate (%)
float64 4.7
100
⌀ | 95% CI (%)
stringlengths 10
13
⌀ | Sample Size
int64 9
63.4k
⌀ |
|---|---|---|---|---|---|---|---|---|---|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2019
|
Age
|
19 Months
| 93.5
|
88.0 to 96.6
| 263
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2018
|
Age
|
19 Months
| 95.2
|
91.0 to 97.5
| 293
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2018-2019
|
Age
|
19 Months
| 91.8
|
88.3 to 94.3
| 556
|
Polio
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
19 Months
| 89.4
|
81.9 to 94.1
| 143
|
Polio
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
5 Months
| 79.3
|
69.0 to 86.8
| 143
|
Polio
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
13 Months
| 91.7
|
87.4 to 94.7
| 391
|
DTaP
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
5 Months
| 79.3
|
69.0 to 86.8
| 143
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 88.4
|
80.8 to 93.3
| 143
|
PCV
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
3 Months
| 89.2
|
81.7 to 93.9
| 143
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 92
|
87.8 to 94.9
| 391
|
≥1 Dose Varicella
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 62.7
|
51.0 to 73.0
| 143
|
≥1 Dose MMR
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
19 Months
| 79.9
|
69.5 to 87.3
| 143
|
Hep B
|
≥1 Dose, 2 Day
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
0-2 Days
| 86.9
|
81.6 to 90.9
| 391
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 72.9
|
66.0 to 78.9
| 391
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
19 Months
| 39.8
|
29.5 to 51.2
| 143
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 72.1
|
65.4 to 78.0
| 391
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
13 Months
| 89.5
|
84.7 to 92.8
| 391
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 86.5
|
74.5 to 94.6
| 391
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 78.9
|
72.6 to 84.1
| 391
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 90.5
|
85.8 to 93.7
| 391
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 67.3
|
60.5 to 74.0
| 391
|
Hib
|
Primary Series
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 88.5
|
80.8 to 93.4
| 143
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 96.9
|
91.0 to 99.3
| 143
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 77.2
|
67.0 to 86.1
| 143
|
Hib
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
3 Months
| 87.1
|
82.0 to 90.9
| 391
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 90.5
|
86.2 to 93.9
| 391
|
Combined 7 Series
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 71.9
|
65.1 to 78.3
| 391
|
Combined 7 Series
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 80.6
|
67.7 to 90.8
| 391
|
≥1 Dose Varicella
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 86.5
|
81.1 to 91.0
| 391
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 83.1
|
76.9 to 87.8
| 391
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 85.3
|
79.6 to 89.6
| 391
|
Combined 7 Series
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
24 Months
| 72.1
|
61.3 to 82.1
| 143
|
Hep B
|
≥1 Dose, 1 Day
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
0-1 Days
| 84.5
|
78.6 to 88.9
| 391
|
Hib
|
Primary Series
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 92.4
|
88.1 to 95.6
| 391
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 88.8
|
83.8 to 92.8
| 391
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 92.2
|
86.0 to 95.8
| 143
|
≥1 Dose Varicella
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 88.6
|
78.3 to 95.4
| 143
|
Rotavirus
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
8 Months
| 77.6
|
71.0 to 83.0
| 391
|
PCV
|
≥4 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 79.4
|
72.9 to 84.6
| 391
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
0-3 Days
| 86.9
|
81.6 to 90.9
| 391
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 90.3
|
86.0 to 93.7
| 391
|
Polio
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
5 Months
| 78.9
|
72.6 to 84.1
| 391
|
PCV
|
≥4 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 80.6
|
74.4 to 86.0
| 391
|
Polio
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 87.5
|
82.1 to 91.4
| 391
|
≥1 Dose MMR
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 91
|
85.0 to 95.2
| 391
|
≥1 Dose Varicella
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 84.1
|
77.9 to 88.8
| 391
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 90.3
|
85.5 to 93.6
| 391
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 93.4
|
85.5 to 97.8
| 143
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 78.7
|
68.9 to 87.1
| 143
|
Hib
|
Primary Series
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 76.3
|
69.7 to 81.9
| 391
|
Polio
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 93.6
|
89.0 to 96.7
| 391
|
DTaP
|
≥4 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 68.8
|
61.8 to 75.1
| 391
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 73.6
|
67.0 to 79.3
| 391
|
Hib
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
5 Months
| 78.6
|
72.2 to 83.8
| 391
|
Hep B
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
5 Months
| 89.2
|
84.4 to 92.7
| 391
|
Polio
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
3 Months
| 87.3
|
82.2 to 91.1
| 391
|
Hib
|
Primary Series
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 91.1
|
83.9 to 96.0
| 143
|
Rotavirus
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
8 Months
| 77.2
|
66.5 to 85.2
| 143
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 68.6
|
57.9 to 77.7
| 143
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 90.5
|
86.2 to 93.9
| 391
|
Polio
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 90.3
|
85.7 to 93.6
| 391
|
Hib
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 89.8
|
82.2 to 94.3
| 143
|
Hep B
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 92.3
|
88.4 to 95.3
| 391
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
13 Months
| 87.4
|
82.1 to 91.4
| 391
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 58
|
50.6 to 65.6
| 391
|
≥1 Dose MMR
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
19 Months
| 83.8
|
77.6 to 88.5
| 391
|
Polio
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 90.3
|
86.0 to 93.7
| 391
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
35 Months
| 79.7
|
71.2 to 87.1
| 391
|
Hep B
|
≥1 Dose, 3 Day (Birth Dose)
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
0-3 Days
| 84.1
|
74.9 to 90.4
| 143
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
35 Months
| 89.6
|
82.0 to 94.9
| 143
|
PCV
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
3 Months
| 86.5
|
81.2 to 90.4
| 391
|
DTaP
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
5 Months
| 78.9
|
72.5 to 84.1
| 391
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
13 Months
| 64.5
|
57.6 to 70.9
| 391
|
Hep B
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
3 Months
| 95.1
|
91.7 to 97.2
| 391
|
Hib
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 87.4
|
82.0 to 91.3
| 391
|
≥1 Dose Varicella
| null |
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
13 Months
| 61.7
|
54.5 to 68.5
| 391
|
DTaP
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
24 Months
| 89.4
|
82.6 to 94.4
| 143
|
≥1 Dose MMR
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 62.7
|
51.1 to 73.0
| 143
|
Hib
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
7 Months
| 47.1
|
40.0 to 54.4
| 391
|
Hep A
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 84.3
|
78.5 to 89.3
| 391
|
Polio
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
13 Months
| 89.9
|
82.3 to 94.4
| 143
|
PCV
|
≥3 Doses
|
States/Local Areas
|
North Dakota
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 95.8
|
93.6 to 97.9
| 695
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 87.6
|
83.8 to 91.5
| 695
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Overall
|
Overall
| 66.1
|
62.3 to 70.0
| 830
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Poverty
|
<133% FPL
| 54.8
|
45.7 to 64.0
| 155
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Poverty
|
133% to <400% FPL
| 65.2
|
59.7 to 70.8
| 408
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2020-2021
|
Age
|
24 Months
| 79.6
|
73.4 to 85.2
| 391
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2021
|
Age
|
24 Months
| 64.9
|
54.1 to 75.6
| 143
|
Hep B
|
≥1 Dose
|
States/Local Areas
|
North Dakota
|
2021
|
Age
|
3 Months
| 93.4
|
87.4 to 96.6
| 143
|
Hep A
|
≥2 Doses
|
States/Local Areas
|
North Dakota
|
2016-2019
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 63.7
|
49.5 to 77.9
| 120
|
PCV
|
≥4 Doses
|
States/Local Areas
|
North Dakota
|
2016-2019
|
Insurance Coverage
|
Private Insurance Only
| 90.7
|
87.7 to 93.6
| 695
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Race and Ethnicity
|
White, Non-Hispanic
| 68.4
|
64.1 to 72.6
| 637
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Urbanicity
|
Living In a MSA Principal City
| 75.9
|
70.2 to 81.6
| 285
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Urbanicity
|
Living In a MSA Non-Principal City
| 67
|
56.9 to 77.1
| 124
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Urbanicity
|
Living In a Non-MSA
| 57.2
|
51.5 to 62.9
| 421
|
Hib
|
Full Series
|
States/Local Areas
|
North Dakota
|
2016-2019
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 78.9
|
69.4 to 88.3
| 120
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Insurance Coverage
|
Private Insurance Only
| 72.9
|
68.6 to 77.2
| 562
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Insurance Coverage
|
Other
| 52.1
|
33.1 to 71.1
| 42
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Race and Ethnicity
|
Hispanic
| 53.6
|
37.2 to 69.9
| 48
|
Influenza
| null |
States/Local Areas
|
North Dakota
|
2014-2017
|
Race and Ethnicity
|
Other or Multiple Races, Non-Hispanic
| 65
|
54.5 to 75.4
| 123
|
End of preview. Expand
in Data Studio
Vaccination Coverage among Young Children (0-35 Months)
Description
Vaccination Coverage among Young Children (0-35 Months)
• National, regional, state, and selected local area vaccination coverage estimates for 2-year-old children by birth year and birth year cohorts from the National Immunization Survey-Child.
• Additional information available at https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/index.html
Dataset Details
- Publisher: Centers for Disease Control and Prevention
- Last Modified: 2024-09-26
- Contact: NCIRD ([email protected])
Source
Original data can be found at: https://www.cdc.gov/vaccines/imz-managers/coverage/childvaxview/index.html
Usage
You can load this dataset using:
from datasets import load_dataset
dataset = load_dataset('HHS-Official/vaccination-coverage-among-young-children-0-35-mon')
License
This dataset is licensed under http://opendefinition.org/licenses/odc-odbl/
- Downloads last month
- 3